| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/08/2004 | CA2490261A1 Differentiation modulating agents and uses therefor |
| 01/08/2004 | CA2490016A1 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 01/08/2004 | CA2489520A1 A method for the detection of apoptosis |
| 01/08/2004 | CA2487824A1 Oncolytic viruses as phenotyping agents for neoplasms |
| 01/08/2004 | CA2486543A1 Pesticidally active proteins and polynucleotides obtainable from paenibacillus species |
| 01/07/2004 | EP1378751A2 Method of measuring drug-metabolizing enzyme activity, method of evaluating inhibition of drug-metabolizing enzyme activity, and composition for these methods |
| 01/07/2004 | EP1378576A1 Storing and detecting nucleic acid administered to a solid carrier |
| 01/07/2004 | EP1378575A1 Method of detecting inorganic phosphoric acid, pyrophosphoric acid and nucleic acid and method of typing snp sequence of dna |
| 01/07/2004 | EP1378571A1 5' ESTs for secreted proteins expressed in various tissues |
| 01/07/2004 | EP1378569A1 Method of extracting virus gene and extraction apparatus |
| 01/07/2004 | EP1378567A1 Bacterial adpglucose pyrophosphatase, method for obtaining the latter and its use in the production of assay devices and in the obtention of transgenic plants and bacteria |
| 01/07/2004 | EP1378245A2 Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis. Their use in a vaccine |
| 01/07/2004 | EP1377833A2 Gastrointestinal glutathione peroxidase in hepatitis c virus infections |
| 01/07/2004 | EP1377830A2 Arrays for determining binding of biomolecules |
| 01/07/2004 | EP1377828A2 Methods of analysis and labeling of protein-protein interactions |
| 01/07/2004 | EP1377823A1 Automated immunohistochemical and in situ hybridzation assay formulations |
| 01/07/2004 | EP1377686A1 Systems and methods for high throughput genetic analysis |
| 01/07/2004 | EP1377685A2 Method of detecting macromolecular biopolymers by means of an electrode arrangement |
| 01/07/2004 | EP1377684A1 Methods for identifying small molecules that bind specific rna structural motifs |
| 01/07/2004 | EP1377683A2 Modified random primers for probe labeling |
| 01/07/2004 | EP1377682A1 Methods for the synthesis of polynucleotides and combinatorial libraries of polynucleotides |
| 01/07/2004 | EP1377681A2 Method of separating alleles |
| 01/07/2004 | EP1377680A2 Diagnosis and treatment of cancer: i |
| 01/07/2004 | EP1377679A2 Method and kit for enhancing the association rates of polynucleotides |
| 01/07/2004 | EP1377678A2 Diagnostic and therapeutic use of a caveolae-associated integral membrane protein for alzheimer's disease and related neurodegenerative disorders |
| 01/07/2004 | EP1377676A2 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 01/07/2004 | EP1377669A2 Production of apomictic seed |
| 01/07/2004 | EP1377664A2 Genes encoding proteolytic enzymes from aspargilli |
| 01/07/2004 | EP1377663A2 Intermediates and enzymes of the non-mevalonate isoprenoid pathway |
| 01/07/2004 | EP1377611A2 Muteins of hypoxia inducible factor alpha and methods of use thereof |
| 01/07/2004 | EP1377609A2 Mhc molecule constructs and their uses for diagnosis and therapy |
| 01/07/2004 | EP1377603A1 Protein cluster v |
| 01/07/2004 | EP1377596A1 Ttk in diagnosis and as a therapeutic target in cancer |
| 01/07/2004 | EP1377310A2 Modulation of smooth muscle cell proliferation by vegf-x or antagonists thereof |
| 01/07/2004 | EP1377220A1 Fluorescent cobalamins and uses thereof |
| 01/07/2004 | EP1377165A2 Tsg101-gag interaction and use thereof |
| 01/07/2004 | EP1021556B1 Assay using marked microbial host cell strains |
| 01/07/2004 | EP0880692B1 Disposable test strips for determination of blood analytes, and methods for making same |
| 01/07/2004 | EP0647270B1 Novel malignant cell type markers of the interior nuclear matrix |
| 01/07/2004 | CN2597990Y Bottle for microbe culturing and detecting |
| 01/07/2004 | CN2597989Y Biochip apparatus unit |
| 01/07/2004 | CN2597980Y Monitoring vessel for object surface contamination |
| 01/07/2004 | CN2597478Y Oligonucleotides brobe and chip fixed on solid substrate |
| 01/07/2004 | CN1466683A Assay method with the use of redox reaction |
| 01/07/2004 | CN1466681A Method and apparatus for patch-clamp measurements on cells |
| 01/07/2004 | CN1466631A Process for producing protein decomposition product |
| 01/07/2004 | CN1466627A Method of estimating the genotype of fertility recovery locus to rice BT type male fertility cytoplasm |
| 01/07/2004 | CN1466625A Method of proliferating natural killer cells |
| 01/07/2004 | CN1465717A Determination for specificity of one segmentum gonococcus DNA sequence (4) and use thereof |
| 01/07/2004 | CN1465716A Determination for specificity of one segmentum gonococcus DNA sequence (3) and use thereof |
| 01/07/2004 | CN1465715A Determination for specificity of one segmentum gonococcus DNA sequence (5) and use thereof |
| 01/07/2004 | CN1465714A One segmentum gonococcus DNA sequence (2) specificity detemination and use thereof |
| 01/07/2004 | CN1465713A Determination for specificity of ureaplasma DNA sequence (1) and use thereof |
| 01/07/2004 | CN1465712A Kit for5 forecasting ACEI group hypotensor effect, method, software and compound medicine thereof |
| 01/07/2004 | CN1465711A Method for determining haem mutant gene and solid base material using said method |
| 01/07/2004 | CN1465710A Test tube fixing carried linear nucleic acid chain specimen and making method thereof |
| 01/07/2004 | CN1465709A Risk estimution for diatebic to suffer from diabetic renopathy or blood-lipid imbalance |
| 01/07/2004 | CN1465708A Determination for specificity of candida albicans DNA sequence (3) and use thereof |
| 01/07/2004 | CN1465707A Determination for specificity of Candida albicans DNA sequence (2) and use thereof |
| 01/07/2004 | CN1465706A Determination for specificity of Candida albicans DNA sequence (5) and use thereof |
| 01/07/2004 | CN1465705A Determination for specificity of Candida albicans DNA sequence (4) and use thereof |
| 01/07/2004 | CN1465704A Cancer suppressor gene PINX1 and use thereof |
| 01/07/2004 | CN1465700A Hepatitis c virus tunic protein E2 gene capable of being total length expressed in E. coli, its coding protein and use |
| 01/07/2004 | CN1465696A Polypeptide-trorsine 14 and polynucleotide for coding said polypeptide |
| 01/07/2004 | CN1465587A Polypeptide-chondriosome carrier 18 and polynucleotide for colding said polypeptide |
| 01/07/2004 | CN1465584A SiRNA target sequence bank of SARS virus and use thereof |
| 01/07/2004 | CN1133750C Biochiop and its preparing process |
| 01/07/2004 | CN1133370C Control cell for use in identification of common acute lymphoblast leukemia and preparation process thereof |
| 01/06/2004 | US6673908 Nucleic acid mutant with nucleotide sequence replacements; antiinflammatory agents |
| 01/06/2004 | US6673901 Fibronectins for use as diagnostic and treatment tools in gene therapy |
| 01/06/2004 | US6673899 Protein for use treatment of diabetes |
| 01/06/2004 | US6673898 Estrone sulfate, dehydroepiandrosterone sulfate and/or ochratoxin a; genetically engineered mutant |
| 01/06/2004 | US6673896 Derivatives of soluble T-4 |
| 01/06/2004 | US6673895 Pro-apoptotic fragments of the dengue virus envelope glycoproteins |
| 01/06/2004 | US6673768 Transgenic animal models for cardiac hypertrophy and methods of use thereof (treating) |
| 01/06/2004 | US6673631 Simultaneous isolation and quantitation of DNA |
| 01/06/2004 | US6673621 Contractable; medical equipment for blood, urine, saliva, and cerebrospinal fluid analysis |
| 01/06/2004 | US6673616 Cleavage of nucleic acid with hairpin motif using exo- or endonucleases; detection of bacterial or viral pathogens |
| 01/06/2004 | US6673615 Characterization of individual polymer molecules based on monomer-interface interactions |
| 01/06/2004 | US6673610 Mutating nucleotide sequences; obtain nucleotide sequence, incubate with mutant primers and polymerase, amplify nucleotide sequence, digest recover product, screen for primer sequences |
| 01/06/2004 | US6673601 Plasmid; expression vector encodes glycoprotein |
| 01/06/2004 | US6673600 Transgenic C. elegans as a model organism for investigations on Alzheimer's disease |
| 01/06/2004 | US6673591 Increasing permissiveness of cell to viral replication by decreasing expression of interferon by making cell deficient in factor that regulates interferon expression in vivo |
| 01/06/2004 | US6673579 Methods and compositions for multiplex amplification of nucleic acids |
| 01/06/2004 | US6673578 High speed polymerase chain reactions |
| 01/06/2004 | US6673577 Use to confirm that nucleic acid fragments, possessing putatively identified sequences which have been predicted by use of genecalling(tm), a quantitative expression analysis technique, are actually present in the sample |
| 01/06/2004 | US6673568 Kits; cyanine dyes; bacteria/not specific/; use of fluorescent dye to rapidly quantify viable cells having importance in food, pharmaceutical, environmental, manufacturing and clinic industries |
| 01/06/2004 | US6673567 Analyzing gene expression in microorganisms comprising transforming genetic labels, inserting genes or target dna to form transposons, then cloning, screening and isolating; genetic engineering |
| 01/06/2004 | US6673566 Diagnosis of pathogen infections through analysis of nitrite production by antigen stimulated leukocytes |
| 01/06/2004 | US6673565 Biosensor for use in the detection of preferential particles in sample |
| 01/06/2004 | US6673564 Detecting modulators of polypeptide activity in cell; obtain cell, incubate with modulator, monitor cellular activity and compare to control |
| 01/06/2004 | US6673563 Luminous bacteria and methods for the isolation, identification and quantitation of toxicants |
| 01/06/2004 | US6673560 Use in detection of metal hydrides, enzyme cofactors or diagnostic/medical diagnostic assays using dehydrogenases as reagents, indicators, markers, or labels |
| 01/06/2004 | US6673559 Met proto-oncogene and a method for predicting breast cancer progression |
| 01/06/2004 | US6673555 Methods of using SCAP antagonists |
| 01/06/2004 | US6673554 Protein localization assays for toxicity and antidotes thereto |
| 01/06/2004 | US6673553 Complexing; quantitative analysis |
| 01/06/2004 | US6673552 Analyzing polynucleotides having point mutations or genetic deletions using polypeptides that preferentially bind to the nucleotides, then separating using immunoaffinity chromatography; genetic engineering |
| 01/06/2004 | US6673551 Monitoring nucleotide sequences complementarity in sample; obtain sample, incubate with probe, allow hybridization, screen for accurate complimentarity |
| 01/06/2004 | US6673549 Cdnas differentially expressed in cell cultures treated with steroids or synthetic steroids used to detect metabolic or toxicological response to steroid treatment, diagnose, treat, or monitor treatment of a steroid responsive disorder |